Tel Aviv, Israel
Tel Aviv, Israel

Time filter

Source Type

— Global Augmented Reality and Virtual Reality in Healthcare Market is expected to grow at a CAGR of 17.2% during the forecast period. Growing healthcare expenditure on emerging technologies and devices, rising private funds and greater emphasis on delivery of efficient healthcare services are the key factors driving the market growth. Lack of clear regulatory guidelines for their medical use is restraining the growth of augmented reality and virtual reality in healthcare market. North America is the leading market followed by Europe. Key factors contributing to the market growth in North America are the ease of access to technologies and well-established distribution channels. Emerging markets act as lucrative destinations for players involved in the market. Some of the key players in the market include Siemens Healthcare, CAE Healthcare, Layar B.V, Artificial Life, Inc., Philips Healthcare, Intuitive Surgical Inc., OnStar, LLC, Foursquare Labs, Inc., EON Reality, GE Healthcare, Hologic, Inc., Vuzix Corp, Vital Images, Inc., Simulab Corp, Medtronic, TheraSim, Inc., VirtaMed, Laerdal Medical, WorldViz, LLC, Immersion Corp, Oculus VR, LLC, Aruba Networks and Gowalla. Application Covered: • Fitness Management • Pharmacy benefit Management • Education • Diagnostics • Rehabilitation and Therapeutics • Medical Training • Pain Distraction • Surgical and Diagnostic Imaging • Patient Care Management • Virtual Reality Exposure Therapy (VRET) • Simulation • Other Applications End User Covered: • Advertising Agencies • Hospitals and Clinics • Research laboratories • Community Pharmacy • Pharmaceutical and Biotechnology Companies • Academic Institutes Unit • Government Agencies • Other End User What our report offers: – Market share assessments for the regional and country level segments – Market share analysis of the top industry players – Strategic recommendations for the new entrants – Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets – Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) – Strategic recommendations in key business segments based on the market estimations – Competitive landscaping mapping the key common trends – Company profiling with detailed strategies, financials, and recent developments – Supply chain trends mapping the latest technological advancements About Us Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. For more information, please visit https://www.wiseguyreports.com/sample-request/562752-augmented-reality-and-virtual-reality-in-healthcare-global-market-outlook-2015-2022


(PRLEAP.COM)– According to a new series of reports on the European dental implant fixture and final abutment market by iData Research ( www.idataresearch.com ), a growing prevalence of local manufacturers and increasingly cost-sensitive consumer demographic is contributing to overall price deprecation and the declining market share of premium implants. Historically, premium dental implant companies have dominated the competitive landscape in Europe but have recently faced rising competition from the value and discount brands."The increasing pricing pressure in the market has led premium implant companies to levy significant discounts on their products in order to remain competitive," explains Jeffery Wong, Strategic Analyst Manager at iData Research. "Regions with a larger presence of value and discount brands have been impacted most heavily and this limiting effect on overall growth is expected to continue over the next several years."However, despite persistent price depreciation, both mature and relatively underdeveloped markets continue to generate moderate levels of unit growth, thereby mitigating the net effect on market growth. For example, the key development within the final abutment market is the rapidly increasing uptake of patient-individualized CAD/CAM solutions and focus on digital dentistry. Additionally, a growing number of local laboratories have emerged to produce and distribute CAD/CAM abutments, making them more accessible. Market growth within these segments will be driven by increased penetration in relatively underdeveloped markets, such as France and the United Kingdom.Recent improvements in manufacturing capability and product affordability have resulted in rapid adoption of the CAD/CAM abutments, which offer significant progression in aesthetics and clinical outcomes, relative to the stock and custom cast abutments. It is expected that the European market will continue to adopt CAD/CAM technology, generating consistent growth for the final abutment market.Straumann is the leading competitor in the European dental implant fixture and final abutment market. Straumann's success can be attributed to its comprehensive product portfolio comprising traditional implants and abutments, as well as offerings that include ceramic implants, full arch restorations, CAD/CAM abutments and regenerative dental biomaterials. Furthermore, Straumann has continually reinforced its leading position in the market with strategic investments in value and discount implant companies such as Neodent, Biodenta, Medentika, MegaGen and Anthogyr. Continued expansion through strategic acquisitions and partnerships will aid Straumann in maintaining its leading position in the European dental implant market. Dentsply Sirona holds the second leading position in the market, benefitting from a strong presence across all market segments. Other leading competitors include Nobel Biocare, Zimmer Biomet, CAMLOG, Sweden & Martina, Medentis, MIS Implants and BEGO among others.More on the dental implant market in Europe can be found in a series of reports published by iData Research entitled the European Market Report Suite on Dental Implant Fixtures and Final Abutments . The suite covers reports on the following markets: dental implant fixtures, final abutments, treatment planning software and surgical guides.The iData report series on dental implants covers the U.S., Japan, South Korea, Australia, China,India, Brazil, Argentina, Mexico and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about dental implant market data or procedure data, register online or email us at info@idataresearch.net for a European Market Report Suite on Dental Implant Fixtures and Final Abutments brochure and synopsis.iData Research ( www.idataresearch.com ) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Dental Prosthetics, Dental Lasers, Dental Materials, Dental Bone Graft Substitutes, Dental Implants, Dental CAD/CAM, Dental Operatory Equipment, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics and more.Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. We have built a reputation and earned our clients' trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.


Receive press releases from iHealthcareAnalyst, Inc.: By Email Global Gynecology Devices Market Analysis: Type of Products, Growth Trends and Forecast to 2020, New Findings by iHealthcareAnalyst, Inc. Maryland Heights, MO, February 22, 2017 --( Browse Gynecology Devices Market by Device Type (Surgical Devices: Endoscopy Devices – Hysteroscopes, Colposcopes, Resectoscopes, Laparoscopes, Endoscopic Imaging Systems; Endometrial Ablation Devices – Hydrothermal, Radiofrequency, Balloon-Based; Fluid Management Systems – Female Sterilization and Contraceptive Devices, Permanent Birth Control Devices, Temporary Birth Control Devices; Handheld Instruments: Vaginal Speculum, Tenaculum, Curettes, Trocars, Biopsy Forceps; Diagnostic Imaging System – Ultrasound, Mammography; Gynecological Chairs – Fixed-Height and Adjustable-Height Chairs) 2016-2020 at https://www.ihealthcareanalyst.com/report/gynecology-devices-market/. Gynecology devices refer to the class of medical devices that are used in the treatment, examination, and diagnosis of conditions of the female reproductive system. A wide range of medical devices is used to perform gynecological procedures that includes equipment used to examine the female reproductive organs, collect sample for biopsy, perform endometrial ablation for abnormal uterine bleeding and similar other surgical tasks. The global gynecology devices market report estimates the market size (Revenue USD million – 2013 to 2020) for key market segments based on device type (surgical devices: endoscopy devices – hysteroscopes, colposcopes, resectoscopes, laparoscopes, endoscopic imaging systems; endometrial ablation devices – hydrothermal, radiofrequency, balloon-based; fluid management systems – female sterilization and contraceptive devices, permanent birth control devices, temporary birth control devices; handheld instruments: vaginal speculum, tenaculum, curettes, trocars, biopsy forceps; diagnostic imaging system – ultrasound, mammography; gynecological chairs – fixed-height and adjustable-height chairs), and forecasts growth trends (CAGR% – 2016 to 2020). The global gynecology devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global gynecology devices market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. Major players operating in the global gynecology devices market and included in this report are Boston Scientific Corporation, Hologic, Inc., CooperSurgical, Inc., Ethicon, Inc., Karl Storz GmbH, Medtronic, Inc., Olympus Corporation, Richard Wolf GmbH, and Stryker Corporation. To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/gynecology-devices-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, February 22, 2017 --( PR.com )-- The global gynecology devices market is estimated to reach USD 20.5 Billion by 2020, due to increasing adoption of minimal invasive technologies worldwide. Prevalence of diseases such as menorrhagia, uterine fibroids, and cervical cancers has increased globally has increased demand for gynecological devices significantly. In addition, lifestyle changes due to change in the status of females in the society have transformed the health need for more sophisticated and advanced gynecological treatments.Browse Gynecology Devices Market by Device Type (Surgical Devices: Endoscopy Devices – Hysteroscopes, Colposcopes, Resectoscopes, Laparoscopes, Endoscopic Imaging Systems; Endometrial Ablation Devices – Hydrothermal, Radiofrequency, Balloon-Based; Fluid Management Systems – Female Sterilization and Contraceptive Devices, Permanent Birth Control Devices, Temporary Birth Control Devices; Handheld Instruments: Vaginal Speculum, Tenaculum, Curettes, Trocars, Biopsy Forceps; Diagnostic Imaging System – Ultrasound, Mammography; Gynecological Chairs – Fixed-Height and Adjustable-Height Chairs) 2016-2020 at https://www.ihealthcareanalyst.com/report/gynecology-devices-market/.Gynecology devices refer to the class of medical devices that are used in the treatment, examination, and diagnosis of conditions of the female reproductive system. A wide range of medical devices is used to perform gynecological procedures that includes equipment used to examine the female reproductive organs, collect sample for biopsy, perform endometrial ablation for abnormal uterine bleeding and similar other surgical tasks.The global gynecology devices market report estimates the market size (Revenue USD million – 2013 to 2020) for key market segments based on device type (surgical devices: endoscopy devices – hysteroscopes, colposcopes, resectoscopes, laparoscopes, endoscopic imaging systems; endometrial ablation devices – hydrothermal, radiofrequency, balloon-based; fluid management systems – female sterilization and contraceptive devices, permanent birth control devices, temporary birth control devices; handheld instruments: vaginal speculum, tenaculum, curettes, trocars, biopsy forceps; diagnostic imaging system – ultrasound, mammography; gynecological chairs – fixed-height and adjustable-height chairs), and forecasts growth trends (CAGR% – 2016 to 2020). The global gynecology devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global gynecology devices market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.Major players operating in the global gynecology devices market and included in this report are Boston Scientific Corporation, Hologic, Inc., CooperSurgical, Inc., Ethicon, Inc., Karl Storz GmbH, Medtronic, Inc., Olympus Corporation, Richard Wolf GmbH, and Stryker Corporation.To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/gynecology-devices-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.


(PRLEAP.COM)According to a new series of reports on the Australia market for vascular access devices by iData Research ( www.idataresearch.com ), the use of peripherally inserted central catheters (PICCs) has grown significantly at the expense of central venous catheter (CVCs). The PIVC segment is growing rapidly as new technologies enter the market to focus on reducing infection rates and make PIVCs safer and easier to use. Nurse-led placement of PICCs has been a catalyst for the increasing adoption of PICCs which significantly lowers overall procedural cost. The combination of these factors will result in overall unit sales growth in the PICCs market.While the markets for traditional devices such as PICCs and CVCs are maturing, companies are actively investing in the development of new technological features that have increased average selling prices (ASPs) for these devices. New technologies are expected to have a significant impact on the vascular access device market. The competition in this market has spurred companies to differentiate their products in order to gain market share. This has consistently led to unique, premium-priced products."The more significant technological advancements will be in electrocardiogram (ECG) tip location," explains Dr. Kamran Zamanian, CEO of iData. "In addition, the increasing use of ultrasound has led to significant growth in the use of PICCs. Increasingly, ultrasound is being used for placement of PIVCs."Previously, implantable ports were thought to be a high potential market, owing to product innovations such as power-injectable implantable ports, dual lumen ports and arm ports. However, multi-lumen implantable ports have not sold as well as previously anticipated and the prices for power-injectable implantable ports have been decreasing dramatically. The price decreases of power-injectable implantable ports have been occurring as those devices become the standard of care in Australia and as manufacturers attempt to keep and gain market share by making their power-injectable devices more economically appealing.C. R. Bard is the leading competitor in the total Australian vascular access market. They are the strongest in the implantable port and PICC market, but also hold a significant share in the port needles market. The company has been extremely aggressive in their marketing and acquisition strategies in the vascular access market. In addition, the company continues to lead the way with new technologies, such as power-injectable devices. C. R. Bard takes advantage of the crossover between market segments and has been able to increase their presence in the rapidly growing complementary markets.Becton Dickinson is the second leading competitor, offering a wide variety of safety products. This company continues to innovate through the introduction of new products such as the Nexiva™ closed system PIVC. Additional competitors in this market include Teleflex Medical, B. Braun, Smiths Medical, Cook Medical, Medcomp, Angiodynamics, Medtronic and Baxter among others. B. Braun continues to invest in the PIVC market, with a particular focus on the safety PIVC segment.More on the vascular access device market in Australia can be found in a report suite published by iData Research entitled the Australia Market Report Suite for Vascular Access Devices and Accessories . The suite covers reports on the following markets: implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs) and dialysis catheters.The iData report series on vascular access devices covers the U.S., Japan, South Korea, Australia, India, China, Brazil and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about vascular access device market data or procedure data, register online or email us at info@idataresearch.net for an Australia Market Report Suite for Vascular Access Devices and Accessories brochure and synopsis.iData Research ( www.idataresearch.com ) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.


(PRLEAP.COM)– iData Research ( www.idataresearch.com ) recently conducted a face-to-face survey for catheterization lab, structural heart and coronary stents during the 2016 Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, DC. Participants included cardiac surgeons, interventional cardiologists, interventional radiologists and general practitioners. Results have shown that clinical outcomes are the main deciding factor for respondents when choosing which brand of coronary stents to use. Respondents gave reasons for choosing a particular device, including price, availability of devices and existing relationships."This latest report is a global survey regarding demographic trends, concerns, experiences and preferences among cardiologists," explains Dr. Kamran Zamanian, CEO of iData. "Our iData team found answers to the questions posed by major cardiovascular device manufacturers regarding what they wanted to learn from the attendees of TCT 2016."Respondents came from a total of 57 countries. Each country has been subsequently categorized into six distinctive geographical regions: North America, Latin America, Europe, the Middle East, Africa and Asia. Within these regions, the United States, Brazil and Argentina represented the top three countries with the most respondents.The Global Survey on Catheterization Labs, Structural Heart and Coronary Stents by iData Research includes responses for the following questions*:*Results for each question are sorted globally and by regioniData's Global Physician Surveys are conducted by highly trained moderators with years of experience in applying iData's rigorous methodology to ensure balanced responses and to elicit keen insight from physicians, surgeons, specialists and other medical professionals. iData's Global Physician Surveys are used to garner brand awareness, product preferences, message feedback and positioning. iData's Physician Surveys allow the inclusion of a diverse range of medical professionals in broader geographical areas. They also eliminate group bias and allow for interactive one-on-one feedback as well as flexibility to expose the respondent to interactive or static media.iData Research ( www.idataresearch.com ) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.


LONDON, Feb. 20, 2017 /PRNewswire/ -- SummaryGlobalData's new report, "India Diagnostic Imaging Market Outlook to 2022", provides key market data on the India Diagnostic Imaging market. The report provides value, in millions of US dollars and volume (in units) within market categories...


LONDON, Feb. 21, 2017 /PRNewswire/ -- Mexico Diagnostic Imaging Market Outlook to 2022 - Angio Suites, Bone Densitometers, Computed Tomography (CT) Systems, Contrast Agents, Contrast Media Injectors, Mammography Equipment, Mobile C-Arms, MRI Systems, Nuclear Imaging Equipment, Ultrasound...


LONDON, Feb. 15, 2017 /PRNewswire/ -- Brazil Diagnostic Imaging Market Outlook to 2022 - Angio Suites, Bone Densitometers, Computed Tomography (CT) Systems, Contrast Agents, Contrast Media Injectors, Mammography Equipment, Mobile C-Arms, MRI Systems, Nuclear Imaging Equipment,...


Royal Philips (NYSE: PHG; AEX: PHIA) today unveiled the Access CT, its newest computed tomography (CT) solution specifically designed for healthcare organizations seeking to establish or enhance CT imaging capabilities at an accessible cost for a high return in value. Philips Access CT provides consistent image quality across a diverse patient population and a wide range of exam types, enabling healthcare organizations to expand care capabilities to treat more patients. As healthcare needs grow across the globe, many healthcare organizations are increasingly challenged to efficiently diagnose and treat a greater number of patients. Health providers looking to enhance their CT capabilities may be faced with challenges such as reimbursement cuts, patient populations with low ability to pay, or inefficiencies related to growth and expansion. For cost-conscious healthcare organizations, a value-focused CT solution such as the Philips Access CT offers the low total cost of ownership and diagnostic confidence needed to drive clinical, financial and operational efficiencies. "Radiology is a crucial component in patient care and Philips' newest, value-centered CT solution can offer quality imaging capabilities at an accessible cost to health providers who may not have access otherwise," said Kees Wesdorp, Business Group Leader, Diagnostic Imaging, Philips. "It's always important that an imaging solution provides the right answer, the first time, but especially so for healthcare organizations that rely on a scanner to cover a wide breadth of patient needs within a more limited budget. Access CT provides the right balance of performance and value to enable organizations with limited budgets to incorporate critical, high-quality imaging capabilities into their care offering." Philips Access CT provides a number of benefits for physicians and organizations to realize true value from their CT investment, including: With the availability of Access CT, providers have a cost-effective solution that can expand care capabilities to treat more patients. To find more information on Access CT and availability in specific countries, visit http://www.philips.com/AccessCT. Follow @PhilipsLiveFrom for updates from the 2017 European Congress of Radiology, and visit http://www.philips.com/ecr for details on Philips' presence at the event. Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 71,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/newscenter. For further information, please contact: Alicia Cafardi Philips Group Communications Tel: +1-412-523-9616 E-mail: Alicia.Cafardi@Philips.com Twitter: @aliciacafardi Kathy O'Reilly Philips Group Communications Tel: +1-978-221-8919 E-mail: Kathy.Oreilly@Philips.com Twitter: @kathyoreilly


News Article | March 3, 2017
Site: www.prweb.com

The parent company of leading healthcare staffing agency, Aureus Medical Group, has been named among the Best Places to Work in Omaha. C&A Industries, Inc., parent company to four staffing and recruitment firms has been recognized for the seventh time in nine years. C&A is included in the large company category organizations with more than 200 employees. Aureus Medical, headquartered in Omaha and the largest of C&A’s firms, specializes in travel nursing, travel therapy, and full time as well as travel opportunities in most all areas of allied health. The annual Best Places to Work in Omaha initiative, sponsored by the Greater Omaha Chamber of Commerce and Baird Holm, recognizes a select number of companies annually based on the results of surveys taken by the employees of participating organizations. Surveys measure employee engagement, satisfaction, morale, opportunities for professional growth, and workplace culture. “C&A is proud to be honored among a group of highly respected organizations,” said Scot Thompson, President and CEO of C&A Industries. “We believe that the catalyst to our success as a staffing provider and employer of choice on a local and national scale is the exceptional group of employees that comprise the C&A team. To be recognized from within, now for the seventh time, means a great deal to us.” Industry-leading training and professional development programs; its award-winning health and wellness program; and a companywide commitment to community involvement and philanthropy are, according to Thompson, key factors in maintaining C&A’s high levels of employee engagement and morale. He adds that year-round employee recognition programs and a focus on communication and idea sharing are also embraced by employees. “We are continually looking for ways to become an even better organization tomorrow than we are today and our employees play a significant role in this effort,” said Thompson. “They are at the heart of our positive and dynamic workplace, demonstrated through their commitment to excellence, spirit of teamwork and generosity, and by living our mission and values. We are fortunate to have the finest group of employees in Omaha and in our industry." C&A will be recognized along with other Best Places to Work in Omaha recipients during a luncheon in May 2017. Aureus Medical Group is a national leader in healthcare staffing specializing in the successful placement of Nursing, Advanced Practice, Cardiopulmonary, Diagnostic Imaging, Medical Laboratory, Neurodiagnostics, Radiation Oncology, and Rehabilitation Therapy professionals, as well as Physicians, in hospitals and medical facilities nationwide. With more than 30 years of experience, Aureus Medical offers a full range of staffing options, including national contract (travel), local contract, and direct hire. Aureus Medical is the largest affiliate of Omaha-based C&A Industries, a leading provider of human capital management solutions for more than 45 years.

Loading Diagnostic Imaging collaborators
Loading Diagnostic Imaging collaborators